Royal Bank of Canada’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-19
| Closed | – | – | 6151 |
|
2016
Q3 | $0 | Sell |
19
-3,750
| -99% | – | ﹤0.01% | 6003 |
|
2016
Q2 | $2K | Buy |
+3,769
| New | +$2K | ﹤0.01% | 5480 |
|
2016
Q1 | – | Sell |
-61
| Closed | – | – | 6173 |
|
2015
Q4 | $0 | Sell |
61
-1,988
| -97% | – | ﹤0.01% | 6407 |
|
2015
Q3 | $13K | Sell |
2,049
-412
| -17% | -$2.61K | ﹤0.01% | 5199 |
|
2015
Q2 | $24K | Buy |
+2,461
| New | +$24K | ﹤0.01% | 5129 |
|
2015
Q1 | – | Sell |
-509,614
| Closed | -$2.73M | – | 6075 |
|
2014
Q4 | $2.73M | Sell |
509,614
-4,100
| -0.8% | -$21.9K | ﹤0.01% | 1723 |
|
2014
Q3 | $2.58M | Sell |
513,714
-2,150
| -0.4% | -$10.8K | ﹤0.01% | 1747 |
|
2014
Q2 | $3.46M | Sell |
515,864
-2,702
| -0.5% | -$18.1K | ﹤0.01% | 1603 |
|
2014
Q1 | $3.75M | Buy |
518,566
+335
| +0.1% | +$2.43K | ﹤0.01% | 1511 |
|
2013
Q4 | $1.95M | Buy |
518,231
+110,073
| +27% | +$415K | ﹤0.01% | 1883 |
|
2013
Q3 | $1.37M | Buy |
+408,158
| New | +$1.37M | ﹤0.01% | 2066 |
|